RegWardenFDA facility compliance records
Facility

CENTERLINE BIOMEDICAL

1 recall(s) on record — most severe on record: Class I.

Activity by year

FDA actions on record by year2025: 1 recalls, 1 inspections20172018201920202021202220232024220252026
  • Recalls (1)
  • Inspections (1)

Devices registered here (1)

  • Computer, Diagnostic, Programmable
    Product code DQK (opens in a new tab) · Class II · Cardiovascular · 21 CFR 870.1425

Recalls & enforcement

  • Class IOngoing2025-04-11
    Centerline Biomedical has determined that the coating on the guidewires for lot 2404-2005 may delaminate during use of the guidewire.

FDA inspections (1)

  • NAI2025-07-02
    No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices

Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “CENTERLINE BIOMEDICAL (FEI 3012154226) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3012154226-centerline-biomedical/

Not open yet

Alerts for CENTERLINE BIOMEDICAL

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.